Security Snapshot

IKANG HEALTHCARE GROUP INC - SPONSORED ADR (KANG) Institutional Ownership

CUSIP: 45174L108

13F Institutional Holders and Ownership History from Q2 2014 to Q1 2019

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • KANG - IKANG HEALTHCARE GROUP INC - SPONSORED ADR is tracked under CUSIP 45174L108.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 52 to 0 between Q4 2018 and Q1 2019.
  • SEC-reported value moved from $379,952,102 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

45174L108

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
20
Latest
n/a
Rows shown
1-20 of 20
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2019 Q1 0 $0 -$373,786,982 0
2018 Q4 18,643,425 $379,952,102 -$85,742,865 $20.38 52
2018 Q3 20,528,557 $369,745,090 -$349,250,798 $18.10 52
2018 Q2 37,753,528 $772,437,999 +$195,656,002 $20.46 63
2018 Q1 28,253,410 $563,659,871 +$85,556,130 $19.95 60
2017 Q4 23,623,116 $373,125,748 -$3,008,539 $15.80 58
2017 Q3 22,969,783 $309,619,067 +$32,967,360 $13.48 50
2017 Q2 20,570,722 $252,398,061 -$1,590,939 $12.27 51
2017 Q1 19,789,282 $288,922,073 +$2,629,851 $14.60 55
2016 Q4 20,104,189 $348,408,087 +$39,883,733 $17.33 58
2016 Q3 16,471,373 $297,885,414 -$38,391,983 $18.08 58
2016 Q2 18,815,520 $352,351,000 -$19,772,398 $18.34 63
2016 Q1 19,327,933 $422,456,561 -$172,114,555 $21.86 72
2015 Q4 27,439,017 $560,761,624 -$28,444,366 $20.44 66
2015 Q3 29,656,203 $438,739,199 +$17,883,216 $14.80 59
2015 Q2 26,995,683 $521,978,032 +$8,870,708 $19.34 71
2015 Q1 27,422,907 $444,860,330 +$91,471,725 $16.22 49
2014 Q4 21,901,871 $329,522,040 +$38,602,813 $15.04 50
2014 Q3 16,207,340 $315,386,920 +$146,415,414 $19.46 37
2014 Q2 9,555,830 $167,268,625 +$143,834,624 $17.34 38
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .